Methods of binding amyloid beta protein having pyroglutamate at the third amino acid residue (3pE abeta) in vivo using anti-3pE abeta antibodies or antigen-binding fragments thereof | Patent Number 11673943

US 11673943 B2
Application Number17104848
Publication NumberUS 20210147528 A1
Pendency2 years, 6 months, 20 days
Filled DateNov 25, 2020
Priority DateNov 3, 2016
Publication DateMay 20, 2021
Expiration DateNov 2, 2036
Inventor/ApplicantsBianca Van Broeck
Marc Vandermeeren
Marc Mercken
Bart Hermans
Astrid Bottelbergs
ExaminesWANG, CHANG YU
Art Unit1649
Technology Center1600
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
See the invalidated claims, subscribe to our Concierge Program.
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.